A Phase 2 Placebo-Controlled, Randomized, Double Blind, Adaptive Dose Trial of the Safety and Efficacy of Inhaled AZD1419 in Adults With Eosinophilic, Moderate to Severe Asthma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Sep 2017
At a glance
- Drugs AZD 1419 (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms INCONTRO
- Sponsors Dynavax Technologies
- 21 Sep 2017 Planned End Date changed from 11 Oct 2018 to 3 Sep 2018.
- 21 Sep 2017 Planned primary completion date changed from 11 Oct 2018 to 3 Sep 2018.
- 21 Sep 2017 Status changed from recruiting to active, no longer recruiting.